| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 104691-81-8 | Glycine,L-prolyl-D-phenylalanyl-L-prolyl- (9CI); Glycine,N-[1-(N-L-prolyl-D-phenylalanyl)-L-prolyl]-; BCH 325 |  | C21H28N4O5 | 詳情 | 供應(yīng)商 | |
| 68957-32-4 | Glycine,N-ethyl-N-[(1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexyl)sulfonyl]-; Glycine,N-ethyl-N-[(tridecafluorohexyl)sulfonyl]- (9CI) |  | C10H8F13NO4S | 詳情 | 供應(yīng)商 | |
| 87494-16-4 | Glycine,L-alanyl-L-seryl-; Glycine,N-(N-L-alanyl-L-seryl)-; 498: PN: WO2005081628 SEQID: 1607 claimed protein; 6:PN: WO2008009751 SEQID: 6 claimed protein |  | C8H15N3O5 | 詳情 | 供應(yīng)商 | |
| 97235-47-7 | Guanosine,2'-deoxy-8-[(7-fluoro-9H-fluoren-2-yl)amino]- |  | C23H21FN6O4 | 詳情 | 供應(yīng)商 | |
| 13716-89-7 | Glycine, L-a-glutamyl-; Glutaramicacid, 4-amino-N-(carboxymethyl)-, stereoisomer (8CI); Glycine, N-L-a-glutamyl-; 4408: PN:WO2005016962 SEQID: 4850 claimed protein; 4408: PN: WO2005019258 SEQID: 4850claimed protein; Glutamylglycine; H-Glu-Gly-OH; Immune disease-associatedprotein PRO91025 (human); L-Glutamyl-glycine; L-a-Glutamylglycine; NSC 186906; a-Glutamylglycine; a-L-Glutamylglycine |  | C7H12N2O5 | 詳情 | 供應(yīng)商 | |
| 2445-85-4 | Glycine,N-[4-(trifluoromethyl)phenyl]-, ethyl ester; Glycine,N-(a,a,a-trifluoro-p-tolyl)-, ethyl ester (7CI,8CI); (4-Trifluoromethylphenylamino)acetic acid ethyl ester; NSC 190359 |  | C11H12F3NO2 | 詳情 | 供應(yīng)商 | |
| 80658-20-4 | 甘草酸二銨鹽 | Glycyrrhizic acid 2NH4 | 無 | 詳情 | 供應(yīng)商 | |
| 84310-45-2 | Guanidine,[(4S)-4-amino-5-hydroxypentyl]- (9CI); Guanidine,(4-amino-5-hydroxypentyl)-, (S)- |  | C6H16N4O | 詳情 | 供應(yīng)商 | |
| 83960-30-9 | Glycine,L-prolyl-L-histidyl-; Glycine,N-(N-L-prolyl-L-histidyl)- |  | C13H19N5O4 | 詳情 | 供應(yīng)商 | |
| 76726-99-3 | Glycine, L-g-glutamyl-S-(2,5-dihydroxyphenyl)-L-cysteinyl-; Glycine,N-[S-(2,5-dihydroxyphenyl)-N-L-g-glutamyl-L-cysteinyl]-; 2-(Glutathion-S-yl)-1,4-hydroquinone; 2-(S-Glutathionyl)hydroquinone |  | C16H21N3O8S | 詳情 | 供應(yīng)商 | |
| 170245-20-2 | Guanylatecyclase-activating peptide II (human reduced) (9CI); 133: PN:WO2005016244 PAGE: 27 unclaimed sequence; 201: PN: WO2008002971 PAGE: 3/5unclaimed sequence; 77: PN: US20060094658 SEQID: 77 claimed protein; L-Leucine,L-phenylalanyl-L-lysyl-L-threonyl-L-leucyl-L-arginyl-L-threonyl-L-isoleucyl-L-alanyl-L-asparaginyl-L-a-aspartyl-L-a-aspartyl-L-cysteinyl-L-a-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl- |  | C108H180N30O36S4 | 詳情 | 供應(yīng)商 | |
| 129992-33-2 | Guanosine5'-(trihydrogen diphosphate), P'-[6-[(4-azido-2-hydroxybenzoyl)amino]hexyl]ester (9CI); GDP-hexanolaminyl-4-azidosalicylic acid |  | C23H31N9O13P2 | 詳情 | 供應(yīng)商 | |
| 754122-14-0 | Glycine,N-[3-(dimethylamino)propyl]-; Glycine, N-[3-(dimethylamino)propyl]- (9CI) |  | C7H16N2O2 | 詳情 | 供應(yīng)商 | |
| 3313-48-2 | Glycinamide,glycyl-N-2-naphthalenyl-, monohydrobromide (9CI); Acetamide,2-(2-aminoacetamido)-N-2-naphthyl-, monohydrobromide (7CI,8CI) |  | C14H16BrN3O2 | 詳情 | 供應(yīng)商 | |
| 749184-31-4 | Glycine,N-[(5-ethyl-2-hydroxyphenyl)methyl]-N-methyl-; Glycine, N-[(5-ethyl-2-hydroxyphenyl)methyl]-N-methyl- (9CI) |  | C12H17NO3 | 詳情 | 供應(yīng)商 | |
| 742015-31-2 | Glycine, N-cyclobutyl-,ethyl ester; Glycine, N-cyclobutyl-, ethyl ester (9CI) |  | C8H15NO2 | 詳情 | 供應(yīng)商 | |
| 724412-98-0 | Guanidine,N-(1-ethyl-4,5-dihydro-1H-imidazol-2-yl)-N'-(1-methylpropyl)-; Guanidine, N-(1-ethyl-4,5-dihydro-1H-imidazol-2-yl)-N-(1-methylpropyl)- (9CI) |  | C10H21N5 | 詳情 | 供應(yīng)商 | |
| 75290-62-9 | Glycine,N-(trifluoroacetyl)-L-cysteinyl-, methyl ester (9CI); Glycine,N-[N-(trifluoroacetyl)-L-cysteinyl]-, methyl ester; N-(Trifluoroacetyl)cysteinylglycine methyl ester |  | C8H11F3N2O4S | 詳情 | 供應(yīng)商 | |
| 712310-41-3 | Guanidine,[(4-methoxyphenyl)methylene]- (9CI); Guanidine,[(4-methoxyphenyl)methylene]-(9CI) |  | C9H11N3O | 詳情 | 供應(yīng)商 | |
| 156074-03-2 | Glycine,N-(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)glycyl-; Glycine,N-[N-(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)glycyl]-; NU/ICRF 602 |  | C18H14N2O6 | 詳情 | 供應(yīng)商 | |